𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt

✍ Scribed by Niveen Saudy; Fuminaka Sugauchi; Yasuhito Tanaka; Seiji Suzuki; Amina Abdel Aal; Mostafa Abo Zaid; Salah Agha; Masashi Mizokami


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
142 KB
Volume
70
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Hepatitis B virus (HBV) and hepatitis D virus (HDV) sequences among HBV carriers from Egypt have not been evaluated sufficiently. The genotypes of HBV isolated from 105 serum samples from Egyptian carriers were determined. Four complete genomes and 11 entire preS1/S2/S genes were sequenced and evaluated. All serum samples were classified into HBV genotype D using serologic and genetic methods. The length of four complete nucleotide sequences was 3,182 bp. In all 15 samples, the common 33 nucleotides (11 amino acids) deletions in the preS1 region specific for HBV genotype D were observed. In the phylogenetic analysis based on the complete nucleotide sequences, all samples were clustered with the HBV isolates reported from previously Western and Mediterranean countries with nucleotide homology ranging from 96.0–98.0%. Of 75 HBsAg positive samples, anti‐HDV was found in 15 (20%), and HDV RNA was detected in 9 of 15 (60%). The proportion of the patients with liver disease was higher in HBV carriers of anti‐HDV positive with HDV RNA than in HBV carriers of anti‐HDV positive without HDV RNA (P < 0.05). In the phylogenetic analysis based on the sequences in nucleotide position 853–1267 of HDV, nine samples were classified into HDV genotype I with the nucleotide homology ranging from 88.3–92.1% (mean; 90.5%) and clustered with HDV strains reported previously from Ethiopia, Somalia, Egypt, and Lebanon. These results indicate that HBV genotype D and HDV genotype I are most prevalent in Egypt, and HDV co‐infection in HBV carriers is related to severity of liver disease. J. Med. Virol. 70:529–536, 2003. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Epidemiological and clinical evaluation
✍ Anis Khan; Fuat Kurbanov; Yasuhito Tanaka; Abeer Elkady; Masaya Sugiyama; Abdusa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

## Abstract The implication of genotypes is recognized increasingly in the clinical course of hepatitis B virus (HBV) and in response to anti‐viral drugs of hepatitis C virus (HCV). Genotypic prevalence of both etiological agents varies geographically and no data are available for Tajikistan. To in

Genotype characterization and phylogenet
✍ Samad Amini-Bavil-Olyaee; Ramin Sarrami-Forooshani; Fereidoun Mahboudi; Farzaneh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

## Abstract Hepatitis B virus (HBV) is one of the major causative agents of acute and chronic liver disease worldwide and is believed to be responsible for a million deaths annually. Eight genotypes of HBV, A to H, have been described on the basis of similarity of the complete genomes sequence. Alt

Hepatitis delta virus genotypes I and II
✍ Alberto Quintero; Nathalie Uzcátegui; Carmen Luisa Loureiro; Leopolodo Villegas; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

## Abstract The genotypes of hepatitis B (HBV) and delta (HDV) viruses circulating among Venezuelan Amerindian populations, where these viruses are endemic, were determined by sequencing of PCR amplified products from HBsAg positive sera. HDV genotype I (n = 7, 6 from West Amerindians), and III (n 

Infection with hepatitis A, B, C, and de
✍ Bira Tsatsralt-Od; Masaharu Takahashi; Kazunori Endo; Osorjin Buyankhuu; Oidov B 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

One hundred ten consecutive patients (60 males and 50 females; age, mean AE standard deviation [SD], 22.6 AE 6.4 years; range 16-48 years) who were clinically diagnosed with sporadic acute hepatitis between December 2004 and January 2005 in Ulaanbaatar, Mongolia, were studied. IgM antibodies to hepa

Diversity of hepatitis B and C viruses i
✍ Federico A. Di Lello; Flavia G. Piñeiro y Leone; Gabriela Muñoz; Rodolfo H. Camp 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

## Abstract Although there is a low prevalence rate (around 1% of the population) of infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) in Chile, little is known about the diversity and molecular characteristics of the circulating viruses. In the present study, 40 HBV and 57 HCV sam

Infection with hepatitis A, B, Delta, An
✍ Dr. Archana Kumar; P. K. Misra; G. S. Rana; Raj Mehrotra 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB

## Abstract Serological markers of hepatitis A, B, and Delta and human immunodeficiency viruses were studied in 25 children receiving cancer chemo‐therapy. Eighty‐eight percent had pre‐existing HAV immunity which was unaltered by chemo‐therapy. HDV infection was observed in 8% while HIV was conspic